SENTI-202, a groundbreaking CAR NK-cell therapy, targets relapsed/refractory AML, offering hope for patients with limited treatment options.

The financing round was jointly led by new investor Regeneron Ventures and current investor Deerfield Management.

The Buss family is selling the Los Angeles Lakers after nearly 50 years of ownership in a record-breaking $10 billion deal to Dodgers owner Mark Walter. NBA legend Magic Johnson, a part-owner of the ...

The trial aims to assess the safety, pharmacodynamics, efficacy, and pharmacokinetics of the therapy in nearly 255 subjects.

WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) announced the issuance of U.S. patent No. 12,329,748 by the United ...